https://aramisbio.com/ 2021-12-15T00:38:48+00:00 https://aramisbio.com/news/ 2022-11-03T12:01:45+00:00 https://aramisbio.com/news-events/ 2021-12-13T13:30:38+00:00 https://aramisbio.com/cookie-policy/ 2021-12-13T15:47:04+00:00 https://aramisbio.com/terms-of-use/ 2021-12-13T15:29:07+00:00 https://aramisbio.com/contact/ 2021-12-14T18:13:21+00:00 https://aramisbio.com/pipeline/ 2021-12-15T13:23:04+00:00 https://aramisbio.com/about/ 2023-01-12T22:06:45+00:00 https://aramisbio.com/privacy-policy/ 2021-12-13T15:29:07+00:00 https://aramisbio.com/news/aramis-biosciences-completes-enrollment-of-its-phase-ii-clinical-trial-evaluating-a197-for-the-treatment-of-dry-eye-disease/ 2022-11-03T12:02:17+00:00 https://aramisbio.com/news/aramis-biosciences-announces-first-patient-dosed-in-phase-ii-clinical-trial-evaluating-a197-for-the-treatment-of-dry-eye-disease/ 2022-02-28T12:50:22+00:00 https://aramisbio.com/news/aramis-biosciences-announces-fda-clearance-of-ind-application-for-a197/ 2022-02-28T12:48:44+00:00 https://aramisbio.com/news/aramis-biosciences-launches-to-address-unmet-needs-in-ocular-immunology/ 2021-12-15T00:25:32+00:00